AbCellera
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
An integrated platform combining biology, computation, and engineering to accelerate antibody drug discovery from target to clinic, with expertise in targeting complex membrane proteins like GPCRs and ion channels.
Description Brand's website · 2026-10-04
AbCellera is a biotechnology company that integrates biology, computation, and engineering to develop impactful antibody-based medicines. They advance an internal pipeline of investigational drugs from target identification through clinical trials for various therapeutic areas.
Offerings
Core capabilities Brand's website · 2026-10-04
- Integrated full-stack platform for antibody discovery and development; investigational antibody-based medicines (e.g.
- ABCL635 for Vasomotor Symptoms
- ABCL575 for Atopic Dermatitis
- ABCL688 for Autoimmunity
- ABCL386 for Oncology).
Pricing Brand's website · 2026-10-04
Future drug sales and strategic licensing agreements for developed antibody-based medicines.
Audience
Target industry Brand's website · 2026-10-04
Patients with unmet medical needs in therapeutic areas such as endocrinology, immunology, and oncology; biopharmaceutical industry for potential partnerships and licensing.
Is this your business?
The information above is publicly sourced — assembled by Optimly from AbCellera's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for AbCellera across the index.
Claim AbCellera — free →Page last updated 2026-10-17.